Diovan
Product Images NDC 68151-4349

3 FDA label images from Carilion Materials Management · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Diovan (NDC 68151-4349). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Valsartan Structural Formula (Diovan Tablets 01)

Valsartan Structural Formula (Diovan Tablets 01)
Chemical structure diagram of the active ingredient in Diovan. The structure shows molecular bonds and rings characteristic of valsartan's chemical composition.*
FDA Label Image

Effects On Mortality Amongst Subgroups In Valiant (Diovan Tablets 02)

Effects On Mortality Amongst Subgroups In Valiant (Diovan Tablets 02)
A forest plot comparing Valsartan versus Captopril across patient subgroups. The x-axis ranges from 0.5 to 1.5, with markers indicating estimates and confidence intervals for each subgroup such as age, gender, race, and medication status. The plot shows which treatment is favored across these subgroups.*
FDA Label Image

Label Image (Lbl681514349)

Label Image (Lbl681514349)
Diovan 80 mg tablets label showing the active ingredient Valsartan. The label indicates the manufacturer as Novartis with lot number F0571 and expiration date 07/14. The package includes a barcode and the prescription-only designation (RX Only).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.